Kodiak Sciences (KOD) Share-based Compensation (2017 - 2026)
Kodiak Sciences (KOD) reported Share-based Compensation of $12.2 million for Q1 2026, down 23.51% on a YoY basis from $15.9 million in Q1 2025, and down 8.51% quarter-over-quarter from $13.3 million in Q4 2025.
Kodiak Sciences (KOD) Share-based Compensation (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Share-based Compensation for 10 years, with the latest figure at $12.2 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 23.51% year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at $55.1 million (down 4.45% YoY), and the FY2025 full-year result was $58.9 million, down 2.24% from the prior year.
- Share-based Compensation for Q1 2026 stood at $12.2 million, down from $13.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $28.1 million in Q1 2022, with the low at $8.6 million in Q4 2024.
- Historically, Share-based Compensation has averaged $19.2 million across 5 years, with a median of $18.4 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 183.07% — and 2024, when it sank 62.25%.
- Kodiak Sciences' Share-based Compensation stood at $25.8 million in 2022, then decreased by 11.44% to $22.8 million in 2023, then slumped by 62.25% to $8.6 million in 2024, then soared by 54.14% to $13.3 million in 2025, then slipped by 8.51% to $12.2 million in 2026.
- The last three Share-based Compensation figures came in at $12.2 million (Q1 2026), $13.3 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26.47 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.16 Mn |
| Mar 31, 2026 | 12.16 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 15.89 Mn |
| Mar 31, 2025 | 15.89 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Jun 30, 2024 | 18.38 Mn |
| Jun 30, 2024 | 18.38 Mn |
| Mar 31, 2024 | 18.41 Mn |
| Mar 31, 2024 | 18.41 Mn |
| Dec 31, 2023 | 22.83 Mn |
| Dec 31, 2023 | 22.83 Mn |